“Attributes of intestinal microbiota composition and their correlation with clinical primary non-response to anti-TNF-α agents in inflammatory bowel disease patients” (2022) Biomolecules and Biomedicine, 22(3), pp. 412–426. doi:10.17305/bjbms.2021.6436.